5247 related articles for article (PubMed ID: 26771115)
21. Unraveling the mystery of cancer metabolism in the genesis of tumor-initiating cells and development of cancer.
Zhang G; Yang P; Guo P; Miele L; Sarkar FH; Wang Z; Zhou Q
Biochim Biophys Acta; 2013 Aug; 1836(1):49-59. PubMed ID: 23523716
[TBL] [Abstract][Full Text] [Related]
22. Mitochondria: The metabolic switch of cellular oncogenic transformation.
Tan YQ; Zhang X; Zhang S; Zhu T; Garg M; Lobie PE; Pandey V
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188534. PubMed ID: 33794332
[TBL] [Abstract][Full Text] [Related]
23. Glutamine reliance in cell metabolism.
Yoo HC; Yu YC; Sung Y; Han JM
Exp Mol Med; 2020 Sep; 52(9):1496-1516. PubMed ID: 32943735
[TBL] [Abstract][Full Text] [Related]
24. Manipulating Metabolic Alterations and their Consequences to Unleash the Potential of Antitumor Immunotherapy.
Zhu X; Zhu L; Wu Y
Curr Protein Pept Sci; 2022; 23(9):585-601. PubMed ID: 35726423
[TBL] [Abstract][Full Text] [Related]
25. Metabolic exchanges within tumor microenvironment.
Chiarugi P; Cirri P
Cancer Lett; 2016 Sep; 380(1):272-80. PubMed ID: 26546872
[TBL] [Abstract][Full Text] [Related]
26. The TCA cycle as a bridge between oncometabolism and DNA transactions in cancer.
Ciccarone F; Vegliante R; Di Leo L; Ciriolo MR
Semin Cancer Biol; 2017 Dec; 47():50-56. PubMed ID: 28645607
[TBL] [Abstract][Full Text] [Related]
27. MYC, Metabolism, and Cancer.
Stine ZE; Walton ZE; Altman BJ; Hsieh AL; Dang CV
Cancer Discov; 2015 Oct; 5(10):1024-39. PubMed ID: 26382145
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
29. Non-canonical functions of enzymes facilitate cross-talk between cell metabolic and regulatory pathways.
Snaebjornsson MT; Schulze A
Exp Mol Med; 2018 Apr; 50(4):1-16. PubMed ID: 29657328
[TBL] [Abstract][Full Text] [Related]
30. The consequences of enhanced cell-autonomous glucose metabolism.
Locasale JW
Trends Endocrinol Metab; 2012 Nov; 23(11):545-51. PubMed ID: 22920571
[TBL] [Abstract][Full Text] [Related]
31. Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis.
Barger JF; Plas DR
Endocr Relat Cancer; 2010 Dec; 17(4):R287-304. PubMed ID: 20699334
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity of tumor-induced gene expression changes in the human metabolic network.
Hu J; Locasale JW; Bielas JH; O'Sullivan J; Sheahan K; Cantley LC; Vander Heiden MG; Vitkup D
Nat Biotechnol; 2013 Jun; 31(6):522-9. PubMed ID: 23604282
[TBL] [Abstract][Full Text] [Related]
33. Clinical development of cancer therapeutics that target metabolism.
Clem BF; O'Neal J; Klarer AC; Telang S; Chesney J
QJM; 2016 Jun; 109(6):367-72. PubMed ID: 26428335
[TBL] [Abstract][Full Text] [Related]
34. Cancer-related networks: a help to understand, predict and change malignant transformation.
Csermely P; Korcsmáros T
Semin Cancer Biol; 2013 Aug; 23(4):209-12. PubMed ID: 23831276
[TBL] [Abstract][Full Text] [Related]
35. Linking metabolic reprogramming to therapy resistance in cancer.
Morandi A; Indraccolo S
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):1-6. PubMed ID: 28065746
[TBL] [Abstract][Full Text] [Related]
36. Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect.
Sun L; Suo C; Li ST; Zhang H; Gao P
Biochim Biophys Acta Rev Cancer; 2018 Aug; 1870(1):51-66. PubMed ID: 29959989
[TBL] [Abstract][Full Text] [Related]
37. Novel therapeutic targets of tumor metabolism.
Kishton RJ; Rathmell JC
Cancer J; 2015; 21(2):62-9. PubMed ID: 25815845
[TBL] [Abstract][Full Text] [Related]
38. Aberrant regulation of the LIN28A/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer.
Wang T; Wang G; Hao D; Liu X; Wang D; Ning N; Li X
Mol Cancer; 2015 Jun; 14():125. PubMed ID: 26123544
[TBL] [Abstract][Full Text] [Related]
39. Roles of fatty acid metabolism in tumourigenesis: Beyond providing nutrition (Review).
Yu XH; Ren XH; Liang XH; Tang YL
Mol Med Rep; 2018 Dec; 18(6):5307-5316. PubMed ID: 30365095
[TBL] [Abstract][Full Text] [Related]
40. Drivers of the Warburg phenotype.
Cairns RA
Cancer J; 2015; 21(2):56-61. PubMed ID: 25815844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
